As of December 2024, Noxopharm has a market cap of $17.35M. This makes Noxopharm the world's 28899th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $10.96M | -15.49% |
2023 | $12.97M | -51.03% |
2022 | $26.49M | -62.82% |
2021 | $71.24M | -20.41% |
2020 | $89.51M | 75.00% |
2019 | $51.15M | -33.33% |
2018 | $76.72M | -62.83% |
2017 | $206.43M | 169.05% |
2016 | $76.72M | - |